Key result
Worse CMR-derived RV GLS is linked to higher all-cause mortality in AL amyloidosis.
Why the study?
Cardiac involvement determines prognosis in light-chain (AL) amyloidosis, yet the incremental prognostic role of right ventricular deformation assessed by cardiac magnetic resonance (CMR) remained incompletely defined.
Does CMR-derived right ventricular global longitudinal strain predict all-cause mortality in patients with light-chain cardiac amyloidosis?
Cohort (n=100)
Does CMR-derived right ventricular global longitudinal strain predict all-cause mortality in patients with light-chain cardiac amyloidosis?
CMR-derived right ventricular global longitudinal strain independently predicts mortality and provides incremental prognostic value beyond standard Mayo staging in patients with light-chain cardiac amyloidosis.
May enhance prognostication beyond Mayo staging in AL amyloidosis; extends existing models but remains hypothesis-generating pending prospective validation.
Background Cardiac involvement determines prognosis in light-chain (AL) amyloidosis. The incremental prognostic role of right ventricular (RV) deformation assessed by cardiac magnetic resonance (CMR) remains incompletely defined. Methods In a prospective cohort of 100 patients with AL amyloidosis, baseline clinical, biomarker, echocardiographic and CMR parameters were collected. The primary endpoint was all-cause mortality (72-month follow-up). Cox regression assessed associations with outcome. Model discrimination was evaluated using Harrell’s C-index. ROC analysis identified an optimal RV global longitudinal strain (GLS) cut-off, followed by Kaplan–Meier analysis. Results During follow-up, 25 deaths occurred. Baseline CMR and echocardiographic characteristics stratified by survival status (Table 1). CMR-derived RV GLS was the strongest imaging predictor of mortality (HR 1.17 per 1% worsening; 95% CI 1.08–1.28; p<0.001) and remained independently associated with outcome after adjustment for biomarkers and Mayo stage. Addition of RV GLS improved discrimination (C-index 0.595 to 0.710). ROC analysis demonstrated good accuracy (AUC 0.74, 95% CI 0.63–0.85; Figure 1A), and an RV GLS cut-off of −16.4% identified patients with significantly reduced survival (log-rank p<0.001; Figure 1B). Echocardiographic RV GLS showed limited discrimination (AUC 0.62; p=0.16) and modest agreement with CMR (ICC 0.43). Conclusions CMR-derived RV GLS is an independent predictor of mortality and provides incremental prognostic value beyond Mayo staging in AL amyloidosis.
No takes yet. Share an insight, caveat, or question.
Mikros et al. (2026) conducted a cohort in Light-chain (AL) cardiac amyloidosis (n=100). CMR-derived right ventricular global longitudinal strain (RV GLS) per 1% worsening vs. Echocardiographic RV GLS, biomarkers, and Mayo stage was evaluated on All-cause mortality (HR 1.17, 95% CI 1.08-1.28, p=<0.001). CMR-derived RV GLS independently predicted all-cause mortality in AL amyloidosis (HR 1.17 per 1% worsening; 95% CI 1.08-1.28; P<0.001) and improved discrimination beyond Mayo staging.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: